Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol LPA contributors: mct - updated : 23-04-2008
HGNC name lipoprotein, Lp(a)
HGNC id 6667
EXPRESSION
Type restricted
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow   
cells
SystemCellPubmedSpeciesStageRna symbol
Skin/Tegumenthair follicle cell
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • ten types of cysteine-rich, kringle KIV modules, one of which KIV-2 occuring in variable number, from 2 to >40
  • a protease domain (peptidase S1 domain)
  • conjugated GlycoP
    HOMOLOGY
    intraspecies homolog to PLG
    Homologene
    FAMILY peptidase S1 family, plasminogen subfamily
    CATEGORY secretory
    SUBCELLULAR LOCALIZATION extracellular
    text plasma
    basic FUNCTION
  • protease, potential modulator of blood-clotting process
  • having serine proteinase activity, and being able of autoproteolysis
  • playing a crucial role in the maintenance of hair growth
  • association of CCL2 with OLR1 and LPA may play a role in modulating monocyte trafficking during atherogenesis
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • Lpa is a complex of apoliprotein and one glycoprotein both linked by a single disulfide
  • INTERACTION
    DNA
    RNA
    small molecule
    protein receptor P2RY5
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) LPA
    Susceptibility
  • to IDDM (IDDM8)
  • to severe coronary artery disease (CAD)
  • Variant & Polymorphism SNP , other
  • affecting plasma concentration of LPA
  • I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels
  • four SNPs overlapping the SLC22A3-LPAL2-LPA gene cluster associated to risk of coronary artery disease (Tregouet 2009)
  • Candidate gene
    Marker
    Therapy target therapeutic approaches in the treatment of hair loss
    ANIMAL & CELL MODELS